Mukhamedshina et al., 2019 - Google Patents
Mesenchymal stem cell therapy for spinal cord contusion: a comparative study on small and large animal modelsMukhamedshina et al., 2019
View HTML- Document ID
- 5872421225101165309
- Author
- Mukhamedshina Y
- Shulman I
- Ogurcov S
- Kostennikov A
- Zakirova E
- Akhmetzyanova E
- Rogozhin A
- Masgutova G
- James V
- Masgutov R
- Lavrov I
- Rizvanov A
- Publication year
- Publication venue
- Biomolecules
External Links
Snippet
Here, we provide a first comparative study of the therapeutic potential of allogeneic mesenchymal stem cells derived from bone marrow (BM-MSCs), adipose tissue (AD-MSCs), and dental pulp (DP-MSCs) embedded in fibrin matrix, in small (rat) and large (pig) spinal …
- 208000008313 Contusions 0 title abstract description 14
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mukhamedshina et al. | Mesenchymal stem cell therapy for spinal cord contusion: a comparative study on small and large animal models | |
| Silvestro et al. | Stem cells therapy for spinal cord injury: an overview of clinical trials | |
| Chen et al. | Mesenchymal stem cell-derived exosomes ameliorate Alzheimer’s disease pathology and improve cognitive deficits | |
| Krupa et al. | The effect of human mesenchymal stem cells derived from Wharton’s jelly in spinal cord injury treatment is dose-dependent and can be facilitated by repeated application | |
| Lempp et al. | New aspects of the pathogenesis of canine distemper leukoencephalitis | |
| Jung et al. | Tonsil-derived mesenchymal stem cells differentiate into a Schwann cell phenotype and promote peripheral nerve regeneration | |
| He et al. | Recent advances of stem cell therapy for retinitis pigmentosa | |
| Chudickova et al. | The effect of Wharton jelly-derived mesenchymal stromal cells and their conditioned media in the treatment of a rat spinal cord injury | |
| Surugiu et al. | Recent advances in mono-and combined stem cell therapies of stroke in animal models and humans | |
| Joshi et al. | Stem cell therapy for modulating neuroinflammation in neuropathic pain | |
| Daou et al. | Displaced myonuclei in cancer cachexia suggest altered innervation | |
| Choi et al. | An Injectable Hyaluronan–Methylcellulose (HAMC) Hydrogel combined with Wharton’s jelly-derived mesenchymal Stromal cells (WJ-MSCs) promotes degenerative disc repair | |
| Trentini et al. | Apple derived exosomes improve collagen type I production and decrease MMPs during aging of the skin through downregulation of the NF-κB pathway as mode of action | |
| Chen et al. | Dental pulp stem cell-derived factors alleviate subarachnoid hemorrhage-induced neuroinflammation and ischemic neurological deficits | |
| Finkel et al. | Diversity of adult neural stem and progenitor cells in physiology and disease | |
| Chan et al. | Therapeutic potential of human stem cell implantation in alzheimer’s disease | |
| Wang et al. | SKP-SC-EVs mitigate denervated muscle atrophy by inhibiting oxidative stress and inflammation and improving microcirculation | |
| Pajer et al. | Stem cell secretome for spinal cord repair: is it more than just a random baseline set of factors? | |
| Zhang et al. | Central nervous system tissue regeneration after intracerebral hemorrhage: the next frontier | |
| Park et al. | Wharton’s jelly-derived mesenchymal stem cells reduce fibrosis in a mouse model of duchenne muscular dystrophy by upregulating microRNA 499 | |
| Velikic et al. | Harnessing the stem cell niche in regenerative medicine: innovative avenue to combat neurodegenerative diseases | |
| Lee et al. | Ethionamide preconditioning enhances the proliferation and migration of human Wharton’s jelly-derived mesenchymal stem cells | |
| Hata et al. | Sustainable effects of human dental pulp stem cell transplantation on diabetic polyneuropathy in streptozotocine-induced type 1 diabetes model mice | |
| Paprocka et al. | Stem cell therapies for cerebral palsy and autism spectrum disorder—a systematic review | |
| Park et al. | Differentiation of motor neuron-like cells from tonsil-derived mesenchymal stem cells and their possible application to neuromuscular junction formation |